Kenneth Koblan Email & Phone Number
Chief Scientific Officer @ Slate Medicines
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Kenneth Koblan Location
- Boston, MA, US
Kenneth Koblan Work
- Chief Scientific Officer @ (September 2026 - Present)
- Head of Research And Development @ (September 2024 - September 2026)
- Head Development Operations @ Dainippon Sumitomo Pharma, Inc. (July 2023 - June 2024)
- Chief Scientific Officer @ (April 2019 - July 2023)
- Global Head TMED-Translational Medicine and Early Development Head Discovery Sciences @ (June 2011 - July 2023)
- Chief Scientific Officer, Vice President @ (March 2010 - May 2011)
- Vice President and Site Head Rahway Basic Research @ (February 2007 - November 2009)
- Vice President and Site Head West Point Human Health @ (March 2004 - February 2007)
- Executive Director and Dept. Chair @ (March 2003 - March 2004)
- Senior Director and Dept. Chair @ (February 2001 - March 2003)
- Director, Molecular Pharmacology @ (May 1998 - February 2001)
- Associate Director, Dept. of Cancer Research @ (June 1996 - May 1998)
- Research Fellow, Dept. of Cancer Research @ (December 1994 - June 1996)
- Senior Research Biochemist, Dept. of Cancer Research @ (December 1991 - December 1994)
Kenneth Koblan Education
- The Johns Hopkins University
Ph. D. (Biochemistry)
1986-1991 - Massachusetts Institute of Technology
Bachelor of Science (Biology, General)
1982-1986
Kenneth Koblan Skills
- Artificial Intelligence (AI)
- Clinical Development
- Drug Discovery
- Interdisciplinary Collaboration
- Molecular Genetics
- Regulatory Filings
- Translational Medicine
Kenneth Koblan Summary
- Kenneth Koblan, based in Boston, MA, US, is currently a Chief Scientific Officer at Slate Medicines. Kenneth Koblan brings experience from previous roles at Vesalius Therapeutics, Dainippon Sumitomo Pharma, Inc. and Sunovion Pharmaceuticals. Kenneth Koblan holds a 1986 - 1991 Ph. D. in Biochemistry @ The Johns Hopkins University. With a robust skill set that includes Artificial Intelligence (AI), Clinical Development, Drug Discovery, Interdisciplinary Collaboration, Molecular Genetics and more. Kenneth Koblan has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Kenneth Koblan?
Find contact details for 700 million professionals.
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co